We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Supplemental Feedings for the High-Risk Preterm Infants—Reply ONLINE FIRST

Marita de Waard, MD1; Willemijn E. Corpeleijn, MD1,2; Johannes B. van Goudoever, MD, PhD1,2
[+] Author Affiliations
1Department of Pediatrics, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands
2Department of Pediatrics, Emma Children’s Hospital, Academic Medical Center, Amsterdam, the Netherlands
JAMA Pediatr. Published online September 19, 2016. doi:10.1001/jamapediatrics.2016.2358
Text Size: A A A
Published online


In Reply We would like to thank Eidelman, Lima et al, Perrin and Sisk, and Verd for their interest in our recently published article1 and their responding letters to the editor. They discuss important considerations when interpreting our results. As discussed in our article, we acknowledge that the intervention period of our trial was short. We explicitly decided on the 10-day period because a specific goal was to test the hypothesis that the protective effect of human milk against sepsis and necrotizing enterocolitis (NEC) could arise from avoiding immunogenic cow’s milk proteins.2 Therefore, we aimed to compare a completely human milk–based diet with a diet that also contained cows’ milk protein. In the Netherlands, we do not have access to a human milk–based fortifier, and we deemed it unacceptable to postpone the introduction of cow’s milk–based fortifier for longer than 10 days following birth. Furthermore, our retrospective study showed that intake during the first 10 days after birth was associated with morbidity and mortality during the first 60 days.3 Finally, these first postnatal days were suggested to be important for intestinal maturation, with a delay seen in formula-fed infants resulting in a longer period with intestinal permeability in these infants.4 Our results showed no detrimental effect of cow’s milk protein exposition (formula) in the first 10 days after birth.1 This finding justifies further randomized trials with donor milk, supplemented with cow’s milk–based fortifier when needed, conducted through longer periods. We agree that those trials are warranted, considering the costs of running a human milk bank.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





September 19, 2016
Hope K. Lima, MS; Ronald S. Cohen, MD; Thomas E. Young, MD
1Department of Food, Bioprocessing, and Nutrition Sciences, North Carolina State University, Raleigh
2Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California
3Division of Neonatology, WakeMed Health and Hospitals, Raleigh, North Carolina
JAMA Pediatr. Published online September 19, 2016.;():. doi:10.1001/jamapediatrics.2016.2352.
September 19, 2016
Maryanne T. Perrin, PhD; Paula M. Sisk, PhD
1University of North Carolina at Greensboro, Greensboro
2Novant Health Forsyth Medical Center, Winston-Salem, North Carolina
JAMA Pediatr. Published online September 19, 2016.;():. doi:10.1001/jamapediatrics.2016.2355.
September 19, 2016
Arthur I. Eidelman, MD
1Hebrew University School of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel
JAMA Pediatr. Published online September 19, 2016.;():. doi:10.1001/jamapediatrics.2016.2361.
September 19, 2016
Sergio Verd, MD
1Pediatric Unit, La Vileta Surgery, Department of Primary Care, Baleares Health Authority, Balaeres, Spain2Health Sciences Research Institute, Balearic University, Baleares, Spain
JAMA Pediatr. Published online September 19, 2016.;():. doi:10.1001/jamapediatrics.2016.2364.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...